The Global Initiative for Asthma (GINA) Strategy Report provides clinicians with an annually
updated evidence-based strategy for asthma management and prevention, which can be …

Background: The assessment of asthma control is pivotal to the evaluation of treatment
response in individuals and in clinical trials. Previously, asthma control, severity, and …

Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and
annually updated a global strategy for asthma management and prevention that has formed …

Background In patients with mild asthma, as-needed use of an inhaled glucocorticoid plus a
fast-acting β 2 -agonist may be an alternative to conventional treatment strategies. Methods …

Background Patients with mild asthma often rely on inhaled short-acting β 2 -agonists for
symptom relief and have poor adherence to maintenance therapy. Another approach might be …

Severe and Difficult-to-Treat Asthma in Adults | NEJM Skip to main content NEJM Group Follow
Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your …

Background In double-blind, placebo-controlled trials, budesonide–formoterol used on an
as-needed basis resulted in a lower risk of severe exacerbation of asthma than as-needed …

Low-income and middle-income countries (LMICs) bear a disproportionately high burden of
the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including …

The Global Initiative for Asthma (GINA) was established in 1993 by the World Health
Organization and the US National Heart Lung and Blood Institute to improve asthma awareness, …

GINA no longer recommends treating adults/adolescents with asthma with short-acting
bronchodilators alone. Instead, they should receive symptom-driven (in mild asthma) or a daily …